Please login to the form below

Not currently logged in
Email:
Password:

BMS sales up 14 per cent

Successful launches helped second-quarter sales for Bristol-Myers Squibb sales increase 14 per cent according to the pharmaceutical firm’s financial results

Successful launches helped second-quarter sales for Bristol-Myers Squibb (BMS) sales increase 14 per cent according to the pharmaceutical firm's financial results.

US-based BMS had revenue of $5.43bn for the quarter, compared to $4.77bn for the same period in 2010. This increase in revenue was helped by the launch of skin cancer drug Yervoy (ipilimumab) and Nulojix (belatacept), an immunosupressant to be used following a kidney transplant.

The company also saw sales for Plavix (clopidogrel bisulfate) increase 15 per cent to $1.87bn to remain BMS' best-selling product. The drug, which is co-marketed by Sanofi, was granted an extra six months of marketing exclusivity by the US Food and Drug Adminisration (FDA) in January 2011.

In its financial guidance for the year, the company expects high single-digit revenue growth, as well as extra expense in marketing, sales and administration. Advertising expenses are expected to decrease.

28th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics